PAH patients with cardiovascular disease risk had similar hospitalization and mortality rates as those without after a ...

Columnist Colleen Steele says that glimmers are like an antidote to some of the events that spark her caregiving anxiety.

Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

Columnist Anna Jeter is delighted to find themes that are relevant to her life in the fictional narratives of writers and ...

The therapy led to “a statistically significant and clinically meaningful reduction in the risk of clinical worsening events when compared to placebo,” Merck, the company that sells Winrevair, said in ...